Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk

NCT ID: NCT00915707

Last Updated: 2013-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to study the pathways through which short sleep duration or poor sleep quality can lead to an increased risk of developing diabetes and obesity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Diabetes

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

obesity diabetes, risk obesity, diabetes risk related to sleep

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Baseline

Subjects are tested under normal sleep conditions for carbohydrate metabolism and appetite regulation.

Group Type EXPERIMENTAL

Baseline

Intervention Type OTHER

Subjects are allowed time in bed for sleep as their usual time at home.

Sleep restriction

Subjects are tested under sleep restriction for carbohydrate metabolism and appetite regulation.

Group Type EXPERIMENTAL

Sleep restriction

Intervention Type OTHER

Subjects sleep is reduced to 4.5 hours in bed for 4 nights.

Reduced sleep quality

Subjects are tested under a poor sleep quality condition for carbohydrate metabolism and appetite regulation.

Group Type EXPERIMENTAL

Reduced Sleep Quality

Intervention Type OTHER

Subjects sleep quality is reduced for 4 nights.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Baseline

Subjects are allowed time in bed for sleep as their usual time at home.

Intervention Type OTHER

Sleep restriction

Subjects sleep is reduced to 4.5 hours in bed for 4 nights.

Intervention Type OTHER

Reduced Sleep Quality

Subjects sleep quality is reduced for 4 nights.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal weight
* Healthy
* Normal sleep times

Exclusion Criteria

* Sleep disorders
* Overweight
* Diabetes
* Other health conditions
* Excessive caffeine and alcohol intake
* Smoking
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Chicago

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Esra Tasali, MD

Role: PRINCIPAL_INVESTIGATOR

University of Chicago

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Chicago

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14916B

Identifier Type: -

Identifier Source: org_study_id